DE60320429D1 - Zusammensetzung und verfahren zur verwendung bei darmreinigungsverfahren - Google Patents

Zusammensetzung und verfahren zur verwendung bei darmreinigungsverfahren

Info

Publication number
DE60320429D1
DE60320429D1 DE60320429T DE60320429T DE60320429D1 DE 60320429 D1 DE60320429 D1 DE 60320429D1 DE 60320429 T DE60320429 T DE 60320429T DE 60320429 T DE60320429 T DE 60320429T DE 60320429 D1 DE60320429 D1 DE 60320429D1
Authority
DE
Germany
Prior art keywords
composition
patients
procedures
mmol
blood glucose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60320429T
Other languages
English (en)
Inventor
Mats Lake
Ulf Smith
Mette Axelsen
Eva Olausson
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Metcon Medicin AB
Original Assignee
Metcon Medicin AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE0202723A external-priority patent/SE0202723D0/xx
Application filed by Metcon Medicin AB filed Critical Metcon Medicin AB
Application granted granted Critical
Publication of DE60320429D1 publication Critical patent/DE60320429D1/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A61K31/716—Glucans
    • A61K31/718—Starch or degraded starch, e.g. amylose, amylopectin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/10—Laxatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Endocrinology (AREA)
  • Surgery (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Detergent Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Cosmetics (AREA)
DE60320429T 2002-09-13 2003-09-12 Zusammensetzung und verfahren zur verwendung bei darmreinigungsverfahren Expired - Lifetime DE60320429D1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
SE0202723A SE0202723D0 (sv) 2002-09-13 2002-09-13 Composition and method for use in intestinal cleansing procedures
US42532002P 2002-11-12 2002-11-12
PCT/SE2003/001428 WO2004024168A1 (en) 2002-09-13 2003-09-12 Composition and method for use in intestinal cleansing procedures

Publications (1)

Publication Number Publication Date
DE60320429D1 true DE60320429D1 (de) 2008-05-29

Family

ID=31996343

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60320429T Expired - Lifetime DE60320429D1 (de) 2002-09-13 2003-09-12 Zusammensetzung und verfahren zur verwendung bei darmreinigungsverfahren

Country Status (7)

Country Link
US (1) US20050054611A1 (de)
EP (1) EP1545563B1 (de)
JP (1) JP2006506349A (de)
AT (1) ATE392207T1 (de)
AU (1) AU2003259006A1 (de)
DE (1) DE60320429D1 (de)
WO (1) WO2004024168A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2536691C2 (ru) * 2009-06-03 2014-12-27 Апталис Фарма ЮЭс, Инк. L-сахарный агент, очищающий толстую кишку, и его применение
CN103237563A (zh) * 2010-10-08 2013-08-07 味之素株式会社 Ct结肠成像中使用的口服给药用液剂及消化道造影用组合物

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1414121A (en) * 1971-09-15 1975-11-19 Smith W J Antacid composition and its preparation
DE3705874A1 (de) * 1987-02-24 1988-09-01 Laevosan Gmbh & Co Kg Darmspuelloesung
CA1338596C (en) * 1988-09-27 1996-09-17 Hiroyoshi Koyama Granules having core and their production
CA2007387C (en) * 1990-01-09 1996-06-11 Isami Kimura Bowel lavage composition
SE469775B (sv) * 1990-12-21 1993-09-13 Ljungqvist Olle Medical Ab Dryck för preoperativ tillförsel innehållande en kolhydratblandning och användning av sackarider för framställning av drycken
IL112967A0 (en) * 1994-03-15 1995-06-29 Los Angeles Childrens Hospital Pharmaceutical compositions comprising a complex carbohydrate to diminish hypoglycemia in patients with diabetes mellitus
GB2311882B (en) * 1996-04-04 2000-08-09 Videologic Ltd A data processing management system
DK0872242T3 (da) * 1996-11-13 2001-09-10 Cb Fleet Co Inc Tarmrensningssammensætning på basis af coatet natriumphosphat
US6162464A (en) * 1997-03-31 2000-12-19 Inkine Pharmaceutical, Inc. Non-aqueous colonic purgative formulations
JPH11332514A (ja) * 1998-05-22 1999-12-07 Nof Corp バランス栄養食品
US6534487B1 (en) * 1999-08-03 2003-03-18 Childrens Hospital Los Angeles Methods for suppressing appetite and enhancing exercise and recovery
US6316427B1 (en) * 2000-04-04 2001-11-13 Metcon Medicin Ab Treatment for diabetes
JP2004512306A (ja) * 2000-10-25 2004-04-22 メットコン・メディシン・アクチボラゲット 血糖代謝異常の処置のための新規組成物および方法

Also Published As

Publication number Publication date
AU2003259006A1 (en) 2004-04-30
JP2006506349A (ja) 2006-02-23
WO2004024168A8 (en) 2004-12-09
US20050054611A1 (en) 2005-03-10
EP1545563A1 (de) 2005-06-29
WO2004024168A1 (en) 2004-03-25
ATE392207T1 (de) 2008-05-15
EP1545563B1 (de) 2008-04-16

Similar Documents

Publication Publication Date Title
Burton et al. A test of pancreatic function in man based on the analysis of duodenal contents after administration of secretin and pancreozymin
WO2003022288A1 (fr) Compositions nutritionnelles permettant de reguler le niveau de glucose sanguin
WO2006062559A3 (en) Device for enhancing tissue glucose processing
BRPI0608271A2 (pt) controle superior de glicose no sangue em tratamento de diabette
TWI406666B (zh) Niu Zhangzhi for the treatment of diseases
De Frene et al. Free DIEAP and SGAP flap breast reconstruction after abdominal/gluteal liposuction
CN103005057A (zh) 一种降血糖的保健茶及制备方法
JPH0678235B2 (ja) 胃腸粘膜組織障害疾患治療剤
Keys et al. Experimental starvation in man
DE60320429D1 (de) Zusammensetzung und verfahren zur verwendung bei darmreinigungsverfahren
EP1393738A4 (de) Arzneimittel gegen diabetes
EP1108429A3 (de) Verbesserte Aminosäurenzusammensetzung zum Bereitstellen von Aminosäurenergänzungen oder Eiweissersatz, insbesondere zur Behandlung und/oder Verwaltung von bestimmten Erkrankungen
JP6896247B2 (ja) Ｇｌｐ−１分泌促進剤
JP2018070602A (ja) 抗疲労食品組成物および抗疲労剤
CN107212368A (zh) 一种降低血糖保健食品及其制备方法
Tan et al. Caring for dependent older persons
CN101313982B (zh) 中药洋葱浆液、其炮制方法及其用途
CN107865098A (zh) 一种益智健康的荞麦奶粉
Azimi et al. Effect of Aerobic exercise on blood pressure of patients with type 2 diabetes: a randomized controlled trial
郭航远 et al. Changs and clinical significance of QTc interval and QTc dispersion in the patients with acute coronary syndrome
Thanaya Dental Center et al. Effects of Dental Implants on Diabetic Patients
CN111297897A (zh) 一种采用牙髓间充质干细胞改善亚健康的方法
Чорненька et al. EFFECT OF PROLONGED AND INTERMITTENT TREATMENT ON THE CLINICAL COURSE OF PEPTIC ULCER
Guzmán et al. Nutritional status change and its impact on quality of life and functionality in malnourish diabetic patients taking a high calorie, high protein tube feeding with slow release carbohydrates and monounsaturated fatty acids as a sole source of nutrition
Thijs Age-related hypotensive effect of placebo and active treatment in patients older than 60 years

Legal Events

Date Code Title Description
8332 No legal effect for de